search
Back to results

Influence of Cryotherapy Combined to TENS Burst in Patients With Non-specific Chronic Lombar Pain

Primary Purpose

Chronic Low Back Pain

Status
Unknown status
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
Cryotherpy
TENS Burst
TENS Burst Placebo
Education
Sponsored by
Wouber Hérickson de Brito Vieira
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Low Back Pain focused on measuring Low back pain, Analgesia, Physical therapy

Eligibility Criteria

30 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Women who present a regular menstrual cycle of 21-35 days;
  • Body mass index between 18.5 and 30 kg / m2;
  • Low back pain for at least 12 weeks;
  • Diagnosis for the treatment of chronic lumbar of non-specific origin;
  • Not used electrotherapy before;
  • No presenting skin alteration, vascular sensitivity or that hinder a perception of electrical stimulation and allergy to ice.

Exclusion Criteria:

  • Those who are not tolerant and respect the evaluation and / or intervention procedures;
  • Absence in less than two protocol treatment sessions;
  • Initiate during the protocol the use of analgesics and anti-inflammatories;
  • The participants to withdraw their consent to participate in the research.

Sites / Locations

  • Federal University of Rio Grande do Norte

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Placebo Comparator

Experimental

Experimental

Experimental

Arm Label

Control Placebo Group

Cryotherapy Group

TENS Burst Group

TENS Burst and Cryotherapy Group

Arm Description

The subjects of this group will be submitted to TENS bound in placebo mode in the lumbar spine.

The subjects of this group will be submitted to Cryotherapy in the lumbar spine.

The subjects of this group will be submitted to TENS Burst in the lumbar spine.

The subjects of this group will be submitted to TENS Burst and Cryotherapy in the lumbar spine.

Outcomes

Primary Outcome Measures

Change from baseline Pain evaluated by Visual Analog Scale at 1 month
Evaluated from the participants' response to pain questioning on the visual analog scale.
Change from baseline Pain evaluated by Visual Analog Scale at 2 months
Evaluated from the participants' response to pain questioning on the visual analog scale.
Change from baseline Pain evaluated by algometry at 1 month
To evaluate the pain by the pain sensation through the pressure algometer.
Change from baseline Pain evaluated by algometry at 2 months
To evaluate the pain by the pain sensation through the pressure algometer.study completion

Secondary Outcome Measures

Full Information

First Posted
March 17, 2017
Last Updated
April 6, 2017
Sponsor
Wouber Hérickson de Brito Vieira
search

1. Study Identification

Unique Protocol Identification Number
NCT03111199
Brief Title
Influence of Cryotherapy Combined to TENS Burst in Patients With Non-specific Chronic Lombar Pain
Official Title
Influence of Cryotherapy Combined to TENS Burst in Pain, Functional Capacity and Quality of Life Patients With Non-specific Chronic Lombar Pain: A Blind Controlled Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
April 2017
Overall Recruitment Status
Unknown status
Study Start Date
April 17, 2017 (Anticipated)
Primary Completion Date
October 1, 2017 (Anticipated)
Study Completion Date
November 1, 2017 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Wouber Hérickson de Brito Vieira

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to analyze the effects of TENS Burst combined Cryotherapy on painful sensation, functional capacity and quality of life of patients with non-specific chronic pain. Study hypothesis: The TENS Burst combined with Cryotherapy offers a better response in the pain sensation, functional capacity and quality of life of patients with non-specific chronic low back pain when compared to the application of these resources in isolation.
Detailed Description
This is a blind, randomized, controlled clinical trial. The first investigator (PI) will be responsible for evaluations and reassessments; The second investigator (PII) for the process of randomization and instruction of the subjects in the intervention protocol and the third investigator (PIII) for the statistical analyzes. The study collections will take place from April 2017 until November 2017, after approval by the Ethics and Research and Qualification Committee and will be developed at the Rehabilitation Outpatient Clinic of the University Hospital Onofre Lopes - HUOL. The investigators will select 48 individuals recruited non-probabilistically for convenience in HUOL. The sample calculation performed in G POWER software version 3.0.0.1 with 80% "power" defined the number of 40 individuals, adding to that number the 20% of possible losses during the survey. Allocation of the groups will be random, through the website http://www.randomization.com, which will include information such as sample size and number of groups. From this, the site will generate a specific coding for each group, randomly and in the form of blocks, with the following characteristics: sex, women in active cycle and use of oral contraceptives and use of analgesics. In this study, four groups will be considered: control-placebo group (gCP), cryotherapy group (gCrio), TENS Burst group (gTENSb) and Cryotherapy + TENS Burst group (gCrioTENSb). The four groups will receive educational sessions on chronic low back pain. The gCP will also undergo TENS bound in placebo mode, gCrio will undergo cryotherapy, gTENSb will undergo TENS in Burst mode and gCrioTENSb will undergo TENS Cryotherapy + Burst (combined). This protocol is in compliance with the recommendations of the Consolidated Standards of Reporting Trials - CONSORT (http://www.consort-statement.org/) for the execution of randomized clinical trials. At the outset, all subjects will receive general instructions on the procedures to be performed, as well as information about the possible risks and benefits of all stages of the research. Individuals will then be enrolled in the survey through a specially prepared assessment form containing information on identification, sex, age, body mass index, level of education, work activity, employment status, stress, and beliefs about pain, marital status, time of onset of symptoms, presence of dermal conditions, sensitivity, ice allergy and treatment perspective. These subjects will be subject to the evaluation measures under the IP instruction, the IP will not know to which group the subjects belong. The evaluations will be performed before the 1st intervention session and will consist of the evaluation of the pain through the EVA when performing the movement and the pressure pain; Functional ability by the Roland-Morris Questionnaire, Functional Oswestry Index and Finger-to-Ground Distance; Quality of life, questionnaire SF 36 and pleasure / dissatisfaction of the intervention by Felling Scale. To maintain the blindness of the study, each individual at the time of intervention will spend 30 minutes in the intervention room and each group will have a corresponding color for the convenience of P2 (being white, blue, green and yellow). The remaining AV2 and AV3 evaluations will be performed two days after the 10th treatment session and 4 weeks after the last treatment session, respectively, for gCP, gCrio, gTENSb and gCrioTENSb. The women will be evaluated and reassessed in the same phase, the follicular phase of the menstrual cycle to present higher thresholds of sensory perception, and will be used to identify the phases of the cycle of each volunteer following the proposed calendar method and the confirmation of regularity by, at least Less, six posterior menstrual cycles. The evaluations and interventions will be carried out in the evening shift and in the same room with a standard temperature of 24º C. A pilot study will be carried out in order to reproduce what will be done during the evaluation and intervention processes, in order to identify and correcting possible flaws with regard to the proposed procedures.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Low Back Pain
Keywords
Low back pain, Analgesia, Physical therapy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Control Placebo Group
Arm Type
Placebo Comparator
Arm Description
The subjects of this group will be submitted to TENS bound in placebo mode in the lumbar spine.
Arm Title
Cryotherapy Group
Arm Type
Experimental
Arm Description
The subjects of this group will be submitted to Cryotherapy in the lumbar spine.
Arm Title
TENS Burst Group
Arm Type
Experimental
Arm Description
The subjects of this group will be submitted to TENS Burst in the lumbar spine.
Arm Title
TENS Burst and Cryotherapy Group
Arm Type
Experimental
Arm Description
The subjects of this group will be submitted to TENS Burst and Cryotherapy in the lumbar spine.
Intervention Type
Other
Intervention Name(s)
Cryotherpy
Intervention Description
Cryotherapy will be used by means of ice packs over a painful region. The ice will be crushed inside a bag so that it is in an ideal size that provides a coupling in a painful column in the lumbar spine; Once it has been inserted in the plastic bag and before closing it all the air must be removed to avoid a faster thawing of the ice and have difficulties of coupling.
Intervention Type
Other
Intervention Name(s)
TENS Burst
Intervention Description
The TENS Burst therapy will be performed using the KLD Sonophasys EUS 0503 electrotherapy device connected in the current therapy mode with the following parameters: 4Hz frequency, high pulse duration of 200 μsec and the current intensity will be at the maximum amplitude To generate visible muscle contraction without generating pain / discomfort. A channel will be used using self-adhesive electrodes arranged parallel to the erector muscle of the spine, so that the region to be treated is between the electrodes.
Intervention Type
Other
Intervention Name(s)
TENS Burst Placebo
Intervention Description
The TENS Burst placebo therapy will be performed using the KLD Sonophasys EUS 0503 electrotherapy device connected in the current therapy mode with the following parameters: 4Hz frequency, high pulse duration of 200 μsec and the current intensity will be on but without Produce the effects of visible muscle contractions because the channel will not be properly coupled in the apparatus so that the stimulation does not reach the patient. A channel will be used using self-adhesive electrodes arranged parallel to the erector muscle of the spine, so that the region to be treated is between the electrodes.
Intervention Type
Other
Intervention Name(s)
Education
Other Intervention Name(s)
Lesson
Intervention Description
After the electrophysical intervention, a moment of education and awareness will be held, in which the participants will receive information about the purpose of the treatment; Anatomy and biomechanics of the lumbar spine; Chronic non-specific back pain; Cognitive, emotional, genetic, social, and lifestyle factors; Intrinsic and extrinsic physical factors, biopsychosocial model: beliefs of pain and hypervigilance; Concepts of joint protection; Energy conservation and general guidelines.
Primary Outcome Measure Information:
Title
Change from baseline Pain evaluated by Visual Analog Scale at 1 month
Description
Evaluated from the participants' response to pain questioning on the visual analog scale.
Time Frame
1 month
Title
Change from baseline Pain evaluated by Visual Analog Scale at 2 months
Description
Evaluated from the participants' response to pain questioning on the visual analog scale.
Time Frame
2 months
Title
Change from baseline Pain evaluated by algometry at 1 month
Description
To evaluate the pain by the pain sensation through the pressure algometer.
Time Frame
1 month
Title
Change from baseline Pain evaluated by algometry at 2 months
Description
To evaluate the pain by the pain sensation through the pressure algometer.study completion
Time Frame
2 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Women who present a regular menstrual cycle of 21-35 days; Body mass index between 18.5 and 30 kg / m2; Low back pain for at least 12 weeks; Diagnosis for the treatment of chronic lumbar of non-specific origin; Not used electrotherapy before; No presenting skin alteration, vascular sensitivity or that hinder a perception of electrical stimulation and allergy to ice. Exclusion Criteria: Those who are not tolerant and respect the evaluation and / or intervention procedures; Absence in less than two protocol treatment sessions; Initiate during the protocol the use of analgesics and anti-inflammatories; The participants to withdraw their consent to participate in the research.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Wouber H de Brito Vieira, PhD
Phone
3342-2018
Email
hericksonfisio@yahoo.com.br
Facility Information:
Facility Name
Federal University of Rio Grande do Norte
City
Natal
State/Province
RN
ZIP/Postal Code
59072-970
Country
Brazil

12. IPD Sharing Statement

Learn more about this trial

Influence of Cryotherapy Combined to TENS Burst in Patients With Non-specific Chronic Lombar Pain

We'll reach out to this number within 24 hrs